ReproCELL Incorporated

2026/10/05 19:28 Updated
Market Cap: $85.1M (¥13.4B)
Stock Price: $0.87 (¥137)
Exchange Rate: 1 USD = ¥157.73

Notice Regarding Application for Manufacturing and Marketing Approval of Stemchymal, a Cell Therapy Product for Spinocerebellar Ataxia Types 3 and 6 in Japan

Importance:
Page Updated: September 21, 2026
IR Disclosure Date: June 24, 2026
Other

ReproCELL Incorporated

Company overview · Stock price · Financial data · All IR

View company page →